Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Delaby, C; Ladang, A; Martinez-Yriarte, J; Zecca, C; Logroscino, G; Körtvelyessy, P; Tumani, H; Parchi, P; Quadrio, I; Hart, M; Olsen, DA; Alcolea, D; Blennow, K; Fortea, J; Lleo, A; Algeciras-Schimnich, A; Ayrignac, X; Bedel, A; Santos, GAA; Borelli, W; Bouaziz-Amar, E; Baldeiras, I; Bigot-Corbel, E; Bjerke, M; Carretero, Perez, M; Casoli, T; Chabrashvili, T; Chapman, MD; Cusato, J; Dursun, E; Fourier, A; Galimberti, D; Gezen-Ak, D; Gordon, BA; Gouju, J; de, Las, Heras, Florez, S; Hernandez, Sanchez, J; Herwerth, M; Imperiale, D; Kaczorowski, F; Kasuga, K; Keshavan, A; Khalil, M; Kuhle, J; Leithner, C; Lewczuk, P; Letournel, F; Tsolaki, M; Giuffrè, GM; Blanc, MC; Mroczko, B; Martínez, Rodríguez, JE; Musso, G; Kulczynska-Przybik, A; Nogueira, L; Paquet, C; Baiardi, S; Gaetani, L; Parnetti, L; Perez, Garay, R; Poesen, K; Quillard-Muraine, M; Rodriguez, Borja, E; Schraen, S; Terracciano, D; Bachhuber, F; Halbgebauer, S; Tzartos, S; Tzartos, J; Unterwalder, N; Vermunt, L; Wellington, CL; Zetterberg, H; Teunissen, C; Lehmann, S.
Clinical use and reporting of neurofilament quantification in neurological disorders: A global overview.
Alzheimers Dement. 2025; 21(6): e70343 Doi: 10.1002/alz.70343
PubMed FullText FullText_MUG

 

Autor*innen der Med Uni Graz:
Khalil Michael
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
INTRODUCTION: Neurofilament light chain (NfL) quantification aids in diagnosing and predicting neurological disorders, but clinical and laboratory practices vary across centers. Differences in result interpretation and reporting further challenge test commutability. This study aimed to review the global analytical and post-analytical methods used for NfL measurement in routine clinical practice across different contexts. METHODS: We established an international working group (WG) and distributed a survey to its members to gather information on context of use (COU), (pre) analytical methods, cutoff usage, as well as the interpretation and reporting of NfL measurements. RESULTS: Among the centers, 63% measured NfL in cerebrospinal fluid (CSF), 87% in blood, and 53% in both. COU was widespread, with 50% defining pathological cutoffs based on publications and 42% considering age. Reporting was primarily done through numeric results (95%). DISCUSSION: Harmonizing cutoffs, reporting, and interpretation across various clinical contexts will facilitate the incorporation of this biomarker into routine clinical practice. HIGHLIGHTS: Unique international overview of current analytical and post-analytical methods for neurofilament light chain (NfL) measurement in routine clinical practice. Tailored sheets for each neurological application. Strategies to harmonize cutoffs, reporting, and interpretation of NfL's measurement.
Find related publications in this database (using NLM MeSH Indexing)
Humans - administration & dosage
Neurofilament Proteins - cerebrospinal fluid, blood
Nervous System Diseases - diagnosis, cerebrospinal fluid
Biomarkers - cerebrospinal fluid, blood

© Med Uni Graz • Impressum